Sarcoma Alliance For Research Through Collaboration
Clinical trials sponsored by Sarcoma Alliance For Research Through Collaboration, explained in plain language.
-
Promising drug targets rare cancer that Won't stop growing
Disease control Recruiting nowThis study tests a drug called nab-sirolimus in 41 people with a rare cancer of the blood vessels called epithelioid hemangioendothelioma (EHE) that is getting worse or causing symptoms. The drug is given through a vein twice every three weeks. The main goal is to see if it shrin…
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
New hope for rare sarcoma: tebentafusp trial launches
Disease control Recruiting nowThis study tests a drug called tebentafusp in people with a rare cancer called clear cell sarcoma that has spread or cannot be removed by surgery. Only patients with a specific genetic marker (HLA-A*02:01) can join. The main goal is to see if the drug can keep the cancer from gro…
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated May 11, 2026 20:49 UTC